-51.9%
NVO vs EMR
+58.0%
-109.9%
-74.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | -1.3% | +0.1% | -0.8% |
| 7D | -7.4% | -1.2% | -6.1% | -7.0% |
| 30D | -5.5% | -9.4% | +3.9% | -2.8% |
| 3M | +4.1% | +8.6% | -4.5% | +0.5% |
| 6M | +19.3% | +6.7% | +12.6% | +15.1% |
| YTD | -9.2% | +13.1% | -22.2% | -14.3% |
| 1Y | -15.0% | +12.7% | -27.8% | -19.9% |
| All | -51.9% | +58.0% | -109.9% | -57.6% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling